{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:47:21Z","timestamp":1774352841703,"version":"3.50.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.12784.BD"],"award-info":[{"award-number":["2022.12784.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00215\/2020"],"award-info":[{"award-number":["UIDB\/00215\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/00215\/2020"],"award-info":[{"award-number":["UIDP\/00215\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0064\/2020"],"award-info":[{"award-number":["LA\/P\/0064\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2021.03439. CEECIND"],"award-info":[{"award-number":["2021.03439. CEECIND"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is recognized as one of the most prevalent endocrinopathy in women at reproductive age. As affected women tend to have poorer assisted reproductive technology (ART) outcomes, PCOS has been suggested to endanger oocyte quality and competence development. The aim of this systematic review was to summarize the available evidence on how the follicular fluid (FF) profile of women with PCOS undergoing <jats:italic>in vitro<\/jats:italic> fertilization (IVF) treatment differs from the FF of normo-ovulatory women. For that, an electronic search in PubMed and Web of Science databases was conducted (up to December 2021). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses - PRISMA guidelines were followed, and the Newcastle-Ottawa Scale was used to assess the risk of bias in the included studies. Data retrieved from papers included (n=42), revealed that the FF composition of women with PCOS compared to those without PCOS predominantly diverged at the following molecular classes: oxidative stress, inflammatory biomarkers, growth factors and hormones. Among those biomarkers, some were proposed as being closely related to pathophysiological processes, strengthening the hypothesis that low-grade inflammation and oxidative stress play a critical role in the pathogenesis of PCOS. Notwithstanding, it should be noticed that the available data on PCOS FF fingerprints derives from a limited number of studies conducted in a relatively small number of subjects. Furthermore, phenotypic heterogeneity of PCOS hampers wider comparisons and weakens putative conclusions. Therefore, future studies should be focused at comparing well characterized patient subgroups according to phenotypes.<\/jats:p>","DOI":"10.1007\/s11154-023-09819-z","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T07:01:34Z","timestamp":1690354894000},"page":"1045-1073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: A systematic review"],"prefix":"10.1007","volume":"24","author":[{"given":"Mafalda V.","family":"Moreira","sequence":"first","affiliation":[]},{"given":"Em\u00eddio","family":"Vale-Fernandes","sequence":"additional","affiliation":[]},{"given":"In\u00eas C.","family":"Albergaria","sequence":"additional","affiliation":[]},{"given":"Marco G.","family":"Alves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-1831","authenticated-orcid":false,"given":"Mariana P.","family":"Monteiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"issue":"10","key":"9819_CR1","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067\u201373.","journal-title":"Hum Reprod"},{"issue":"6","key":"9819_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687\u2013708.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"9819_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270\u201384.","journal-title":"Nat Rev Endocrinol"},{"issue":"13","key":"9819_CR4","first-page":"853","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S. Polycystic Ovary Syndrome. 1995;333(13):853\u201361.","journal-title":"Polycystic Ovary Syndrome."},{"issue":"3","key":"9819_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertility and Sterility. 2018;110(3):364\u201379.","journal-title":"Fertility and Sterility"},{"issue":"2","key":"9819_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/09513590.2017.1371691","volume":"34","author":"T Artimani","year":"2018","unstructured":"Artimani T, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecological Endocrinology. 2018;34(2):148\u201352.","journal-title":"Gynecological Endocrinology"},{"issue":"10","key":"9819_CR7","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s10815-014-0307-z","volume":"31","author":"P Piomboni","year":"2014","unstructured":"Piomboni P, et al. Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet. 2014;31(10):1269\u201376.","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"9819_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/0974-1208.101020","volume":"5","author":"S Rajani","year":"2012","unstructured":"Rajani S, et al. Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive oxygen species levels in follicular fluid and its relationship with IVF-ET outcome. J Hum Reprod Sci. 2012;5(2):187\u201393.","journal-title":"J Hum Reprod Sci"},{"issue":"5","key":"9819_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3109\/01443615.2016.1148683","volume":"36","author":"N Yilmaz","year":"2016","unstructured":"Yilmaz N, et al. Follicular fluid total antioxidant capacity levels in PCOS. J Obstet Gynaecol. 2016;36(5):654\u20137.","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"9819_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/humupd\/dmq032","volume":"17","author":"J Qiao","year":"2011","unstructured":"Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17(1):17\u201333.","journal-title":"Hum Reprod Update"},{"key":"9819_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bpobgyn.2016.03.008","volume":"37","author":"TT Piltonen","year":"2016","unstructured":"Piltonen TT. Polycystic ovary syndrome: Endometrial markers. Best Pract Res Clin Obstet Gynaecol. 2016;37:66\u201379.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"9819_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10815-018-1143-3","volume":"35","author":"MG Da Broi","year":"2018","unstructured":"Da Broi MG, et al. Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications. Journal of Assisted Reproduction and Genetics. 2018;35(5):735\u201351.","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"3","key":"9819_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tem.2016.11.008","volume":"28","author":"S Palomba","year":"2017","unstructured":"Palomba S, Daolio J, La Sala GB. Oocyte Competence in Women with Polycystic Ovary Syndrome. Trends in Endocrinology and Metabolism. 2017;28(3):186\u201398.","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"1","key":"9819_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/jrf.0.0370189","volume":"37","author":"RG Edwards","year":"1974","unstructured":"Edwards RG. Follicular fluid. J Reprod Fertil. 1974;37(1):189\u2013219.","journal-title":"J Reprod Fertil"},{"issue":"2","key":"9819_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10815-006-9103-8","volume":"24","author":"N Jan\u010dar","year":"2007","unstructured":"Jan\u010dar N, et al. Effect of apoptosis and reactive oxygen species productionin human granulosa cells on oocyte fertilizationand blastocyst development. Journal of Assisted Reproduction and Genetics. 2007;24(2):91\u20137.","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"1","key":"9819_CR16","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1038\/s41598-022-08423-6","volume":"12","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, et al. Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome. Scientific reports. 2022;12(1):4359\u20134359.","journal-title":"Scientific reports"},{"issue":"2","key":"9819_CR17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1210\/jc.2014-2086","volume":"100","author":"AS Ambekar","year":"2015","unstructured":"Ambekar AS, et al. Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development. J Clin Endocrinol Metab. 2015;100(2):744\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9819_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12958-019-0490-y","volume":"17","author":"Z Sun","year":"2019","unstructured":"Sun Z, et al. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry. Reproductive Biology and Endocrinology. 2019;17(1):45.","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"3","key":"9819_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLOS Medicine. 2021;18(3): e1003583.","journal-title":"PLOS Medicine"},{"key":"9819_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ\u202f: British Medical Journal. 2015;349: g7647.","journal-title":"BMJ : British Medical Journal"},{"issue":"2","key":"9819_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/09513590.2017.1371691","volume":"34","author":"T Artimani","year":"2018","unstructured":"Artimani T, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2018;34(2):148\u201352.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"9819_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000270900","volume":"69","author":"R Chattopadhayay","year":"2010","unstructured":"Chattopadhayay R, et al. Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecol Obstet Invest. 2010;69(3):197\u2013202.","journal-title":"Gynecol Obstet Invest"},{"issue":"10","key":"9819_CR23","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s10815-021-02241-x","volume":"38","author":"A Naigaonkar","year":"2021","unstructured":"Naigaonkar A, et al. Altered redox status may contribute to aberrant folliculogenesis and poor reproductive outcomes in women with polycystic ovary syndrome. J Assist Reprod Genet. 2021;38(10):2609\u201323.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"9819_CR24","first-page":"449","volume":"19","author":"K Gongadashetti","year":"2021","unstructured":"Gongadashetti K, et al. Follicular fluid oxidative stress biomarkers and ART outcomes in PCOS women undergoing in vitro fertilization: A cross-sectional study. Int J Reprod Biomed. 2021;19(5):449\u201356.","journal-title":"Int J Reprod Biomed"},{"issue":"4","key":"9819_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10815-014-0190-7","volume":"31","author":"AK Seleem","year":"2014","unstructured":"Seleem AK, et al. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. J Assist Reprod Genet. 2014;31(4):499\u2013504.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"9819_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4274\/balkanmedj.2017.1140","volume":"35","author":"EN Tola","year":"2018","unstructured":"Tola EN, et al. The Role of Follicular Fluid Thiol\/Disulphide Homeostasis in Polycystic Ovary Syndrome. Balkan Med J. 2018;35(4):306\u201310.","journal-title":"Balkan Med J"},{"issue":"7","key":"9819_CR27","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s10815-016-0704-6","volume":"33","author":"B Wang","year":"2016","unstructured":"Wang B, et al. Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome. J Assist Reprod Genet. 2016;33(7):959\u201365.","journal-title":"J Assist Reprod Genet"},{"issue":"12","key":"9819_CR28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1080\/09513590.2019.1622087","volume":"35","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study. Gynecol Endocrinol. 2019;35(12):1072\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"9819_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2020.103083","volume":"138","author":"H Zhang","year":"2020","unstructured":"Zhang H, et al. IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with unexplained infertility to PCOS during in vitro fertilization. J Reprod Immunol. 2020;138: 103083.","journal-title":"J Reprod Immunol"},{"key":"9819_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cyto.2016.12.020","volume":"91","author":"Z Niu","year":"2017","unstructured":"Niu Z, et al. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization. Cytokine. 2017;91:180\u20136.","journal-title":"Cytokine"},{"key":"9819_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejogrb.2017.09.017","volume":"218","author":"D Zhou","year":"2017","unstructured":"Zhou D, et al. Increased expression of PGRN protein in follicular fluid and mRNA in granulosa cells in overweight patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2017;218:106\u201312.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"9819_CR32","unstructured":"Oz\u00f6rnek MH, et al.\u00a0Epidermal growth factor and leukemia inhibitory factor levels in follicular fluid. Association with in vitro fertilization outcome.\u00a0J Reprod Med. 1999;44(4):367-369."},{"issue":"4","key":"9819_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.rbmo.2017.12.020","volume":"36","author":"Z Li","year":"2018","unstructured":"Li Z, et al. Leukaemia inhibitory factor in serum and follicular fluid of women with polycystic ovary syndrome and its correlation with IVF outcome. Reprod Biomed Online. 2018;36(4):483\u20139.","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"9819_CR34","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/rheumatology\/kep199","volume":"48","author":"H Maillard-Lefebvre","year":"2009","unstructured":"Maillard-Lefebvre H, et al. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology. 2009;48(10):1190\u20136.","journal-title":"Rheumatology"},{"issue":"11","key":"9819_CR35","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s10815-017-1011-6","volume":"34","author":"D Garg","year":"2017","unstructured":"Garg D, et al. Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS. J Assist Reprod Genet. 2017;34(11):1507\u201313.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"9819_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/REP-16-0359","volume":"153","author":"B Wang","year":"2017","unstructured":"Wang B, et al. Decreased levels of sRAGE in follicular fluid from patients with PCOS. Reproduction. 2017;153(3):285\u201392.","journal-title":"Reproduction"},{"issue":"1","key":"9819_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cyto.2014.09.002","volume":"74","author":"I Kahyaoglu","year":"2015","unstructured":"Kahyaoglu I, et al. Granulocyte colony-stimulating factor: A relation between serum and follicular fluid levels and in-vitro fertilization outcome in patients with polycystic ovary syndrome. Cytokine. 2015;74(1):113\u20136.","journal-title":"Cytokine"},{"issue":"1","key":"9819_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mefs.2015.11.001","volume":"21","author":"M Kudsy","year":"2016","unstructured":"Kudsy M, Alhalabi M, Al-Quobaili F. Follicular fluid Vascular Endothelial Growth Factor (VEGF) could be a predictor for pregnancy outcome in normo-responders and polycystic ovary syndrome women undergoing IVF\/ICSI treatment cycles. Middle East Fertility Society Journal. 2016;21(1):52\u20136.","journal-title":"Middle East Fertility Society Journal"},{"issue":"11","key":"9819_CR39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/1933719110376980","volume":"17","author":"SI Savchev","year":"2010","unstructured":"Savchev SI, et al. Follicular fluid-specific distribution of vascular endothelial growth factor isoforms and sFlt-1 in patients undergoing IVF and their correlation with treatment outcomes. Reprod Sci. 2010;17(11):1036\u201342.","journal-title":"Reprod Sci"},{"key":"9819_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1477-7827-12-82","volume":"12","author":"R Tal","year":"2014","unstructured":"Tal R, et al. Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation. Reprod Biol Endocrinol. 2014;12:82.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"9819_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/REP-20-0077","volume":"160","author":"L Fang","year":"2020","unstructured":"Fang L, et al. High GDF-8 in follicular fluid is associated with a low pregnancy rate in IVF patients with PCOS. Reproduction. 2020;160(1):11\u20139.","journal-title":"Reproduction"},{"issue":"2","key":"9819_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1530\/rep.1.00989","volume":"132","author":"M Uzumcu","year":"2006","unstructured":"Uzumcu M, et al. Immunolocalization of the hepatocyte growth factor (HGF) system in the rat ovary and the anti-apoptotic effect of HGF in rat ovarian granulosa cells in vitro. Reproduction. 2006;132(2):291\u20139.","journal-title":"Reproduction"},{"issue":"2","key":"9819_CR43","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/jcp.22361","volume":"226","author":"MC Guglielmo","year":"2011","unstructured":"Guglielmo MC, et al. The effect of hepatocyte growth factor on the initial stages of mouse follicle development. Journal of Cellular Physiology. 2011;226(2):520\u20139.","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"9819_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.fertnstert.2012.08.059","volume":"99","author":"N \u015eahin","year":"2013","unstructured":"\u015eahin N, et al. The levels of hepatocyte growth factor in serum and follicular fluid and the expression of c-Met in granulosa cells in patients with polycystic ovary syndrome. Fertility and Sterility. 2013;99(1):264-269.e3.","journal-title":"Fertility and Sterility"},{"issue":"4","key":"9819_CR45","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1095\/biolreprod.107.062273","volume":"77","author":"J Buratini Jr","year":"2007","unstructured":"Buratini J Jr, et al. Expression and Function of Fibroblast Growth Factor 10 and Its Receptor, Fibroblast Growth Factor Receptor 2B, in Bovine Follicles1. Biology of Reproduction. 2007;77(4):743\u201350.","journal-title":"Biology of Reproduction"},{"issue":"1","key":"9819_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13048-018-0455-3","volume":"11","author":"Y Liu","year":"2018","unstructured":"Liu Y, et al. Intrafollicular fibroblast growth factor 13 in polycystic ovary syndrome: relationship with androgen levels and oocyte developmental competence. Journal of Ovarian Research. 2018;11(1):87.","journal-title":"Journal of Ovarian Research"},{"issue":"1","key":"9819_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.fertnstert.2012.08.059","volume":"99","author":"N \u015eahin","year":"2013","unstructured":"\u015eahin N, et al. The levels of hepatocyte growth factor in serum and follicular fluid and the expression of c-Met in granulosa cells in patients with polycystic ovary syndrome. Fertil Steril. 2013;99(1):264-269.e3.","journal-title":"Fertil Steril"},{"issue":"1","key":"9819_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13048-018-0455-3","volume":"11","author":"Y Liu","year":"2018","unstructured":"Liu Y, et al. Intrafollicular fibroblast growth factor 13 in polycystic ovary syndrome: relationship with androgen levels and oocyte developmental competence. J Ovarian Res. 2018;11(1):87.","journal-title":"J Ovarian Res"},{"key":"9819_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/980429","volume":"2014","author":"G Garruti","year":"2014","unstructured":"Garruti G, et al. Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome. Biomed Res Int. 2014;2014: 980429.","journal-title":"Biomed Res Int"},{"issue":"11","key":"9819_CR50","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1177\/1933719118818899","volume":"26","author":"KL Hu","year":"2019","unstructured":"Hu KL, et al. Increased Expression of KISS1 and KISS1 Receptor in Human Granulosa Lutein Cells-Potential Pathogenesis of Polycystic Ovary Syndrome. Reprod Sci. 2019;26(11):1429\u201338.","journal-title":"Reprod Sci"},{"issue":"12","key":"9819_CR51","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1210\/jc.2007-0978","volume":"92","author":"MG Li","year":"2007","unstructured":"Li MG, et al. Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2007;92(12):4771\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9819_CR52","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00404-020-05899-3","volume":"303","author":"C Zhang","year":"2021","unstructured":"Zhang C, et al. \u03b2-Edorphin predict pregnancy outcome of PCOS and DOR women after IVF-ET. Arch Gynecol Obstet. 2021;303(5):1207\u201316.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"9819_CR53","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1002\/jcb.27756","volume":"120","author":"Y Liu","year":"2019","unstructured":"Liu Y, et al. Effect of sex hormone-binding globulin polymorphisms on the outcome of in vitro fertilization-embryo transfer for polycystic ovary syndrome patients: A case-control study. J Cell Biochem. 2019;120(3):4675\u201386.","journal-title":"J Cell Biochem"},{"key":"9819_CR54","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fendo.2020.00641","volume":"11","author":"D Dewailly","year":"2020","unstructured":"Dewailly D, et al. Role of Anti-M\u00fcllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2020;11:641.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"9819_CR55","first-page":"3","volume":"22","author":"Z Shaaban","year":"2019","unstructured":"Shaaban Z, et al. Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome. Iran J Basic Med Sci. 2019;22(1):3\u201316.","journal-title":"Iran J Basic Med Sci"},{"key":"9819_CR56","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2147\/IJGM.S25639","volume":"4","author":"S Parco","year":"2011","unstructured":"Parco S, et al. Serum anti-M\u00fcllerian hormone as a predictive marker of polycystic ovarian syndrome. Int J Gen Med. 2011;4:759\u201363.","journal-title":"Int J Gen Med"},{"issue":"6","key":"9819_CR57","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00404-019-05332-4","volume":"300","author":"XH Liu","year":"2019","unstructured":"Liu XH, Wu XH, Yang S. Changes and correlations of anti-M\u00fcllerian hormone and stem-cell factors in different ovarian reserve patients during GnRH-antagonist protocol and the effects on controlled ovarian hyperstimulation outcomes. Arch Gynecol Obstet. 2019;300(6):1773\u201383.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"9819_CR58","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1177\/0300060517704140","volume":"45","author":"Y Chen","year":"2017","unstructured":"Chen Y, et al. Predicting the outcome of different protocols of in vitro fertilization with anti-Mu\u00fcllerian hormone levels in patients with polycystic ovary syndrome. J Int Med Res. 2017;45(3):1138\u201347.","journal-title":"J Int Med Res"},{"issue":"3","key":"9819_CR59","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/09513590.2011.593667","volume":"28","author":"N Yilmaz","year":"2012","unstructured":"Yilmaz N, et al. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome. Gynecol Endocrinol. 2012;28(3):162\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"9819_CR60","doi-asserted-by":"crossref","unstructured":"Zeydabadi Nejad S, Ramezani Tehrani F,Zadeh-Vakili A.\u00a0The Role of Kisspeptin in Female Reproduction. Int J Endocrinol Metab. 2017;15(3):e44337.","DOI":"10.5812\/ijem.44337"},{"issue":"9","key":"9819_CR61","first-page":"2753","volume":"12","author":"AM Polak","year":"2020","unstructured":"Polak AM, et al. The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome. 2020;12(9):2753.","journal-title":"The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome."},{"issue":"11","key":"9819_CR62","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nm1195-1155","volume":"1","author":"M Maffei","year":"1995","unstructured":"Maffei M, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine. 1995;1(11):1155\u201361.","journal-title":"Nature Medicine"},{"issue":"4","key":"9819_CR63","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40618-015-0392-6","volume":"39","author":"HA Inal","year":"2016","unstructured":"Inal HA, et al. The impact of follicular fluid adiponectin and ghrelin levels based on BMI on IVF outcomes in PCOS. J Endocrinol Invest. 2016;39(4):431\u20137.","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"9819_CR64","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/09513590.2019.1594761","volume":"35","author":"A Bousmpoula","year":"2019","unstructured":"Bousmpoula A, et al. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles. Gynecological Endocrinology. 2019;35(9):803\u20136.","journal-title":"Gynecological Endocrinology"},{"issue":"6","key":"9819_CR65","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1365-2265.1984.tb00114.x","volume":"20","author":"DC Cumming","year":"1984","unstructured":"Cumming DC, et al. EVIDENCE FOR DECREASED ENDOGENOUS DOPAMINE AND OPIOID INHIBITORY INFLUENCES ON LH SECRETION IN POLYCYSTIC OVARY SYNDROME. Clinical Endocrinology. 1984;20(6):643\u20138.","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"9819_CR66","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1210\/jcem.83.5.4775","volume":"83","author":"M Guido","year":"1998","unstructured":"Guido M, et al. Involvement of Ovarian Steroids in the Opioid-Mediated Reduction of Insulin Secretion in Hyperinsulinemic Patients with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 1998;83(5):1742\u20135.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"9819_CR67","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00404-018-4793-6","volume":"298","author":"N Jaschke","year":"2018","unstructured":"Jaschke N, et al. Beta endorphin in serum and follicular fluid of PCOS- and non-PCOS women. Arch Gynecol Obstet. 2018;298(1):217\u201322.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"9819_CR68","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12020-014-0504-7","volume":"49","author":"C Duran","year":"2015","unstructured":"Duran C, et al. Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome. Endocrine. 2015;49(2):464\u20139.","journal-title":"Endocrine"},{"issue":"1","key":"9819_CR69","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ijgo.13581","volume":"155","author":"H Gao","year":"2021","unstructured":"Gao H, et al. Thyroid-stimulating hormone level is negatively associated with fertilization rate in patients with polycystic ovary syndrome undergoing in vitro fertilization. International Journal of Gynecology & Obstetrics. 2021;155(1):138\u201345.","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"6","key":"9819_CR70","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.fertnstert.2008.12.024","volume":"93","author":"Y Nafiye","year":"2010","unstructured":"Nafiye Y, et al. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertil Steril. 2010;93(6):1864\u20139.","journal-title":"Fertil Steril"},{"issue":"9","key":"9819_CR71","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/09513590.2019.1594761","volume":"35","author":"A Bousmpoula","year":"2019","unstructured":"Bousmpoula A, et al. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles. Gynecol Endocrinol. 2019;35(9):803\u20136.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"9819_CR72","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ijgo.13581","volume":"155","author":"H Gao","year":"2021","unstructured":"Gao H, et al. Thyroid-stimulating hormone level is negatively associated with fertilization rate in patients with polycystic ovary syndrome undergoing in vitro fertilization. Int J Gynaecol Obstet. 2021;155(1):138\u201345.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"9819_CR73","doi-asserted-by":"publisher","first-page":"16306","DOI":"10.1038\/s41598-019-52856-5","volume":"9","author":"AE Butler","year":"2019","unstructured":"Butler AE, et al. Expression of microRNA in follicular fluid in women with and without PCOS. Sci Rep. 2019;9(1):16306.","journal-title":"Sci Rep"},{"issue":"12","key":"9819_CR74","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1080\/09513590.2019.1622087","volume":"35","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study. Gynecological Endocrinology. 2019;35(12):1072\u20137.","journal-title":"Gynecological Endocrinology"},{"issue":"5","key":"9819_CR75","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0006-2952(02)01157-7","volume":"64","author":"E Duplus","year":"2002","unstructured":"Duplus E, Forest C. Is there a single mechanism for fatty acid regulation of gene transcription? Biochemical Pharmacology. 2002;64(5):893\u2013901.","journal-title":"Biochemical Pharmacology"},{"issue":"11","key":"9819_CR76","doi-asserted-by":"publisher","first-page":"E2269","DOI":"10.1210\/jc.2013-3942","volume":"99","author":"Z Niu","year":"2014","unstructured":"Niu Z, et al. Associations Between Insulin Resistance, Free Fatty Acids, and Oocyte Quality in Polycystic Ovary Syndrome During In Vitro Fertilization. The Journal of Clinical Endocrinology & Metabolism. 2014;99(11):E2269\u201376.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"46","key":"9819_CR77","doi-asserted-by":"publisher","first-page":"80472","DOI":"10.18632\/oncotarget.19058","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, et al. Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients. Oncotarget. 2017;8(46):80472\u201380.","journal-title":"Oncotarget"},{"issue":"5990","key":"9819_CR78","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1126\/science.1188280","volume":"329","author":"N Ouchi","year":"2010","unstructured":"Ouchi N, et al. Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity. Science. 2010;329(5990):454\u20137.","journal-title":"Science"},{"issue":"4","key":"9819_CR79","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/eci.12052","volume":"43","author":"M Carstensen","year":"2013","unstructured":"Carstensen M, et al. Sfrp5 correlates with insulin resistance and oxidative stress. European Journal of Clinical Investigation. 2013;43(4):350\u20137.","journal-title":"European Journal of Clinical Investigation"},{"issue":"3","key":"9819_CR80","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.diabres.2012.11.026","volume":"99","author":"Z Hu","year":"2013","unstructured":"Hu Z, Deng H, Qu H. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Research and Clinical Practice. 2013;99(3):391\u20135.","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"6","key":"9819_CR81","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s11033-018-4360-z","volume":"45","author":"ZO Inal","year":"2018","unstructured":"Inal ZO, Inal HA, Erdem S. The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome. Molecular Biology Reports. 2018;45(6):2037\u201344.","journal-title":"Molecular Biology Reports"},{"issue":"4","key":"9819_CR82","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1095\/biolreprod.110.084434","volume":"83","author":"HM Brown","year":"2010","unstructured":"Brown HM, et al. ADAMTS1 Cleavage of Versican Mediates Essential Structural Remodeling of the Ovarian Follicle and Cumulus-Oocyte Matrix During Ovulation in Mice1. Biology of Reproduction. 2010;83(4):549\u201357.","journal-title":"Biology of Reproduction"},{"issue":"6","key":"9819_CR83","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10815-017-0913-7","volume":"34","author":"EN Tola","year":"2017","unstructured":"Tola EN, et al. Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome. J Assist Reprod Genet. 2017;34(6):811\u20136.","journal-title":"J Assist Reprod Genet"},{"issue":"11","key":"9819_CR84","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s10815-015-0582-3","volume":"32","author":"H Timur","year":"2015","unstructured":"Timur H, et al. The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics. 2015;32(11):1637\u201342.","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"11","key":"9819_CR85","doi-asserted-by":"publisher","first-page":"E2269","DOI":"10.1210\/jc.2013-3942","volume":"99","author":"Z Niu","year":"2014","unstructured":"Niu Z, et al. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab. 2014;99(11):E2269-76.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9819_CR86","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s10815-015-0582-3","volume":"32","author":"H Timur","year":"2015","unstructured":"Timur H, et al. The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome. J Assist Reprod Genet. 2015;32(11):1637\u201342.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"9819_CR87","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s11033-018-4360-z","volume":"45","author":"ZO Inal","year":"2018","unstructured":"Inal ZO, Inal HA, Erdem S. The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome. Mol Biol Rep. 2018;45(6):2037\u201344.","journal-title":"Mol Biol Rep"},{"key":"9819_CR88","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.taap.2019.01.008","volume":"365","author":"Y Sun","year":"2019","unstructured":"Sun Y, et al. High copper levels in follicular fluid affect follicle development in polycystic ovary syndrome patients: Population-based and in vitro studies. Toxicol Appl Pharmacol. 2019;365:101\u201311.","journal-title":"Toxicol Appl Pharmacol"},{"key":"9819_CR89","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coemr.2020.04.005","volume":"12","author":"CR McCartney","year":"2020","unstructured":"McCartney CR, Campbell RE. Abnormal GnRH Pulsatility in Polycystic Ovary Syndrome: Recent Insights. Curr Opin Endocr Metab Res. 2020;12:78\u201384.","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"5","key":"9819_CR90","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-X","volume":"45","author":"RL Cate","year":"1986","unstructured":"Cate RL, et al. Isolation of the bovine and human genes for M\u00fcllerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986;45(5):685\u201398.","journal-title":"Cell"},{"issue":"11","key":"9819_CR91","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","volume":"105","author":"LME Moolhuijsen","year":"2020","unstructured":"Moolhuijsen LME, Visser JA. Anti-M\u00fcllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. The Journal of Clinical Endocrinology & Metabolism. 2020;105(11):3361\u201373.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"9819_CR92","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. The Journal of Steroid Biochemistry and Molecular Biology. 2018;182:27\u201336.","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"1","key":"9819_CR93","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12958-018-0391-5","volume":"16","author":"J Lu","year":"2018","unstructured":"Lu J, et al. A novel and compact review on the role of oxidative stress in female reproduction. Reproductive Biology and Endocrinology. 2018;16(1):80.","journal-title":"Reproductive Biology and Endocrinology"},{"key":"9819_CR94","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014: 360438.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"9819_CR95","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13048-017-0342-3","volume":"10","author":"C Freitas","year":"2017","unstructured":"Freitas C, et al. Follicular Fluid redox involvement for ovarian follicle growth. Journal of Ovarian Research. 2017;10(1):44.","journal-title":"Journal of Ovarian Research"},{"key":"9819_CR96","doi-asserted-by":"crossref","unstructured":"Popko K, et al.\u00a0Proinflammatory cytokines Il-6 and TNF-\u03b1 and the development of inflammation in obese subjects. Eur J Med Res. 2010;15 Suppl 2(Suppl 2):120-2.","DOI":"10.1186\/2047-783X-15-S2-120"},{"issue":"1","key":"9819_CR97","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejogrb.2010.02.010","volume":"150","author":"P Vural","year":"2010","unstructured":"Vural P, et al. Tumor necrosis factor \u03b1 (\u2212308), interleukin-6 (\u2212174) and interleukin-10 (\u22121082) gene polymorphisms in polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2010;150(1):61\u20135.","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"11","key":"9819_CR98","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.cellsig.2013.06.013","volume":"25","author":"J Xie","year":"2013","unstructured":"Xie J, et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cellular Signalling. 2013;25(11):2185\u201397.","journal-title":"Cellular Signalling"},{"issue":"1","key":"9819_CR99","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/humrep\/det383","volume":"29","author":"Z Merhi","year":"2014","unstructured":"Merhi Z. Advanced glycation end products and their relevance in female reproduction. Human Reproduction. 2014;29(1):135\u201345.","journal-title":"Human Reproduction"},{"issue":"4","key":"9819_CR100","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3945\/an.115.008433","volume":"6","author":"J Uribarri","year":"2015","unstructured":"Uribarri J, et al. Dietary Advanced Glycation End Products and Their Role in Health and Disease. Advances in Nutrition. 2015;6(4):461\u201373.","journal-title":"Advances in Nutrition"},{"issue":"6","key":"9819_CR101","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.fertnstert.2005.05.059","volume":"84","author":"PM Lam","year":"2005","unstructured":"Lam PM, Haines C. Vascular endothelial growth factor plays more than an angiogenic role in the female reproductive system. Fertility and Sterility. 2005;84(6):1775\u20138.","journal-title":"Fertility and Sterility"},{"issue":"2","key":"9819_CR102","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/0006-291X(91)91276-I","volume":"181","author":"MS Pepper","year":"1991","unstructured":"Pepper MS, et al. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochemical and Biophysical Research Communications. 1991;181(2):902\u20136.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"9819_CR103","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.rbmo.2010.01.007","volume":"20","author":"P Peitsidis","year":"2010","unstructured":"Peitsidis P, Agrawal R. Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review. Reproductive BioMedicine Online. 2010;20(4):444\u201352.","journal-title":"Reproductive BioMedicine Online"},{"issue":"7","key":"9819_CR104","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1210\/jc.2006-2846","volume":"92","author":"MB Stanek","year":"2007","unstructured":"Stanek MB, et al. Insulin and Insulin-Like Growth Factor Stimulation of Vascular Endothelial Growth Factor Production by Luteinized Granulosa Cells: Comparison between Polycystic Ovarian Syndrome (PCOS) and Non-PCOS Women. The Journal of Clinical Endocrinology & Metabolism. 2007;92(7):2726\u201333.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"9819_CR105","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.","journal-title":"BMC Med"},{"issue":"3","key":"9819_CR106","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0049-0172(90)90055-K","volume":"20","author":"DR Schultz","year":"1990","unstructured":"Schultz DR, Arnold PI. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum. 1990;20(3):129\u201347.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-023-09819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-023-09819-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-023-09819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T08:16:27Z","timestamp":1701764187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-023-09819-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["9819"],"URL":"https:\/\/doi.org\/10.1007\/s11154-023-09819-z","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"19 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}